About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study in Healthy Volunteers | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT03596697

A Study in Healthy Volunteers

This is three part study that will, in part one assess the safety, tolerability, and PK of a single dose of CRV431 in healthy volunteers. The second part of the study will be a single dose drug-drug i...

Lead sponsor: Hepion Pharmaceuticals, Inc.•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Hepion Pharmaceuticals, Inc.

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Capable of giving written informed consent
•Willing and able to complete all study requirements
•Healthy male or female between 18 and 55 years of age (inclusive);
•Body mass index 16 to 32 kg/m2 (inclusive);

Exclusion Criteria

•Positive test for HCVAb or HIVAb. For healthy subjects only: positive test for HBsAg
•Current or history of abuse of alcohol or illicit drugs
•Received an investigational drug, vaccine or medical device within 90 days prior to first dose of study drug.
•Evidence of significant liver fibrosis or cirrhosis
•History of NAFLD or NASH
•Positive test for HDV

Related studies

RECRUITINGPhase 2

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis

RECRUITINGPhase 2

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

NCT06510699 · Fungal Infection, Haematological Malignancy, and more

DILIN - Prospective Study

NCT00345930 · Liver Diseases

RECRUITINGPhase 2

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150 · Chronic Hepatitis B

RECRUITINGPhase 2

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698 · Liver Diseases, Alcoholic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 1, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment92

Start dateJul 2019

Last updatedDec 1, 2021

Condition

Hepatitis B Infectious Disease Liver Diseases

Locations shown

Celerion, Inc

Tempe, Arizona

Celerion, Inc

Lincoln, Nebraska

Pinnacle Clinical Research

San Antonio, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 1, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions